Puma Biotechnology | Passività Correnti



Current Liabilities Cambiamento Data
Agios Pharmaceuticals USD 52.37M 28.79M 2025-03
Alnylam Pharmaceuticals USD 1.08B 110.65M 2025-03
Amgen USD 23.01B 91M 2025-03
Biogen USD 5.3B 231.4M 2025-03
BioMarin Pharmaceutical USD 628.21M 21.22M 2025-03
Daiichi Sankyo JPY 754.03B 41.68B 2025-03
Exelixis USD 399.1M 4.67M 2025-04
Gilead Sciences USD 12B 279M 2024-12
Glaxosmithkline GBP 21.7B 238M 2024-12
Incyte USD 1.89B 244.96M 2025-03
MacroGenics USD 55.53M 3.78M 2024-12
Moderna USD 1.6B 602M 2025-03
Novartis USD 28.69B 560M 2024-12
Pfizer USD 36.45B 6.54B 2025-03
PTC Therapeutics USD 595.39M 14.41M 2025-03
Regeneron Pharmaceuticals USD 3.57B 2.13B 2025-03
Roche Holding CHF 27.02B 424M 2024-12
Sarepta Therapeutics USD 605.59M 126.1M 2025-03
Takeda JPY 2.51T 408.56B 2025-03
TG Therapeutics USD 90.68M 34.43M 2024-12
Ultragenyx Pharmaceutical USD 344.15M 59.14M 2024-12
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12



Puma Biotechnology Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.